Clinical relevance of non-neuronal auto-antibodies in patients with anti-Hu or anti-Yo paraneoplastic diseases.

J Neurooncol

INSERM U 495 and Fédération de Neurologie Mazarin, Hôpital de la Pitié-Salpêtrière, Paris, France.

Published: January 2005

About half of the patients with paraneoplastic diseases develop an immune response against neuronal antigens expressed by both the tumor and the nervous system. In 31 patients with anti-Hu antibodies and 19 patients with anti-Yo antibodies, we searched for the presence of additional non-neuronal auto-antibodies and further studied whether the presence of such auto-antibodies was correlated with a specific oncological or neurological presentation. Positive antinuclear antibodies (ANA) were found at a titer of 1:40 or above in 48% patients with anti-Hu antibodies, and in 37% patients with anti-Yo antibodies. Anti-cytoplasmic antibodies were also detected in 42% patients with anti-Yo antibodies. No specific correlation between the presence of non-neuronal auto-antibodies and clinical characteristics of the patients could be identified. In particular, neither the type of underlying cancer, the overall survival, the tumor response to treatment, nor the neurological presentation were related to the serological status.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11060-004-4536-3DOI Listing

Publication Analysis

Top Keywords

non-neuronal auto-antibodies
12
patients anti-hu
12
patients anti-yo
12
anti-yo antibodies
12
patients
8
paraneoplastic diseases
8
anti-hu antibodies
8
neurological presentation
8
antibodies
7
clinical relevance
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!